Smith & Nephew (LON:SN) Receives Overweight Rating from JPMorgan Chase & Co.

JPMorgan Chase & Co. reiterated their overweight rating on shares of Smith & Nephew (LON:SN) in a report published on Friday morning, MarketBeat reports.

A number of other equities analysts have also commented on the company. Deutsche Bank Aktiengesellschaft raised their price target on Smith & Nephew from GBX 1,300 to GBX 1,400 and gave the stock a “hold” rating in a report on Wednesday, August 6th. Citigroup raised their price target on Smith & Nephew from GBX 1,450 to GBX 1,600 and gave the company a “buy” rating in a report on Friday, October 31st. Berenberg Bank upped their target price on shares of Smith & Nephew from GBX 1,100 to GBX 1,300 and gave the stock a “hold” rating in a research report on Thursday, August 7th. Finally, Royal Bank Of Canada boosted their target price on Smith & Nephew from GBX 1,400 to GBX 1,700 and gave the stock an “outperform” rating in a research report on Monday, October 20th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Smith & Nephew presently has a consensus rating of “Moderate Buy” and a consensus target price of GBX 1,487.60.

Smith & Nephew Stock Up 2.0%

SN traded up GBX 24.50 on Friday, hitting GBX 1,266.50. The company’s stock had a trading volume of 4,229,588 shares, compared to its average volume of 343,671. The stock has a market cap of £13.88 billion, a price-to-earnings ratio of 45.60, a P/E/G ratio of 0.46 and a beta of 0.62. The company has a current ratio of 2.51, a quick ratio of 0.84 and a debt-to-equity ratio of 70.22. The stock’s 50 day simple moving average is GBX 1,365.36 and its 200 day simple moving average is GBX 1,220.05.

Insider Activity

In related news, insider Katarzyna Mazur Hofsaess purchased 541 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was bought at an average cost of GBX 1,385 per share, with a total value of £7,492.85. Also, insider Angie Risley acquired 373 shares of the stock in a transaction on Friday, August 22nd. The shares were purchased at an average cost of GBX 1,382 per share, with a total value of £5,154.86. In the last three months, insiders have purchased 4,811 shares of company stock worth $12,947,701. 0.19% of the stock is owned by company insiders.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.